The Pharmacology Center

Filter Your Results

 

News

 

EINSTEIN CHOICE Studies Low-Dose Rivaroxaban to Reduce VTE Recurrence

March 18, 2017 -- The American College of Cardiology (ACC) announced that findings from the EINSTEIN CHOICE study demonstrated that a low dose of the oral anticoagulant rivaro…

GEMINI-ACS-1 Study Evaluates Safety of Rivaroxaban in Post-ACS Patients

March 18, 2017 -- The American College of Cardiology (ACC) announced that findings from the GEMINI-ACS-1 study demonstrated that patients with acute coronary syndrome (AC…

DECISION CTO Compares PCI With Optimal Medical Therapy

March 18, 2017 -- The American College of Cardiology announced the presentation of data from the DECISION CTO randomized trial by lead investigator Seung-Jung Park, MD, at the…

Daiichi Sankyo Begins Study of Edoxaban in AF Patients Undergoing PCI With Stenting

March 10, 2017 -- Daiichi Sankyo Company, Inc. announced that the first patient has been enrolled into the ENTRUST-AF PCI study, which will compare a treatment regimen based o…

Primary Endpoint Met Early in COMPASS Study of Xarelto for CAD and PAD Patients

February 8, 2017 -- Bayer AG and its partner Janssen Research & Development, LLC announced that the phase 3 COMPASS trial has met its primary endpoint ahead of schedu…

Bleeding Avoidance Strategies

With Andrey Espinoza, MD, FACC, FSCAI; Paul A. Gurbel, MD; Sunil V. Rao, MD; and Steven J. Yakubov, MD, FACC, FSCAI

January/February 2017—Experts offer their experience with acute coronary syndrome protocol and how they approach access sites and handle bleeding events.

Meta-Analysis Evaluates CAS Before CABG

January 18, 2017 -- Online in the European Journal of Vascular and Endovascular Surgery (EJVES), Kosmas I. Paraskevas, MD, et al published a study on 30-day outcomes…

BioCardia Begins CardiAMP Pivotal Heart Failure Trial

January 3, 2017 -- BioCardia, Inc. announced the initiation of the CardiAMP Heart Failure pivotal trial. According to the company, the randomized controlled multicente…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.